Pathology and genetics of thyroid carcinoma

Cited by (182)

Items 101–182 of 182

1. Identification of differentiated functional modules in papillary thyroid carcinoma by analyzing differential networks
   Yingluan Wang, Chunxiao Yang · 2017 · Journal of Cancer Research and Therapeutics
2. Primary Leiomyosarcoma of the Thyroid Gland – A Rare Malignancy
   Bhasker Reddy, Vivek Aggarwal, Ajay Ajmani, Seema Sachan, Deepak Khandelwal · 2019 · touchREVIEWS in Endocrinology
3. Molecular genetics of thyroid cancer
   Maha Rebaï, Ahmed Rebaï · 2016 · Genetics Research
4. The effect of positive thyroglobulin antibodies on the prognosis and treatment response in patients with papillary thyroid carcinoma
   Mojgan Sanjari, Marzieh Ordooei, Ladan Amirkhosravi, Ahmad Naghibzadeh‐Tahami, Sarir Nazemi · 2024 · Heliyon
5. The Value of Chinese Thyroid Imaging Report and Data System Combined With Contrast‐Enhanced Ultrasound Scoring in Differential Diagnosis of Benign and Malignant Thyroid Nodules
   Haiyan Cao, Qi Wen Fan, Shuangshuang Zhuo, Tingyue Qi, Hongguang Sun, Xin Rong, Xiao Xiao, Wen Zhang, Linhai Zhu, Lei Wang · 2021 · Journal of Ultrasound in Medicine
6. Genetic Polymorphisms in the PCNXL2 Gene are Risk Factors for Thyroid Cancer in the Chinese Population
   Runmei Hao, Peng Han, Ling Zhang, Ying Bi, Jinfeng Yan, Honghui Li, Yanxia Bai, Chongwen Xu, Baiya Li, Huajing Li · 2021 · Future Oncology
7. Differential Expression of Immune-Modulatory Molecule HLA-E in Non-Neoplastic and Neoplastic Lesions of the Thyroid
   Bruna Riedo Zanetti, Denise Faria Galano Carvalho, N.L.F. Feitosa, Marcela K. Hassumi, Fabiana Alves Miranda-Camargo, Léa Maria Zanini Maciel, Alfredo Ribeiro‐Silva, Edson García Soares · 2013 · International Journal of Immunopathology and Pharmacology
8. Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma
   Ana Luísa Silva, Francisca Evane Celestino do Carmo, Margarida M. Moura, Rita Domingues, Carla Espadinha, Valeriano Alberto Pais Horta Leite, Branca Maria Cavaco, Maria João Bugalho · 2015 · Endocrine
9. Cellular and Molecular Pathology of Head and Neck Tumors
   Adel K. El‐Naggar · 2011 · Springer eBooks
10. Clinicopathologic and molecular disease prognostication for papillary thyroid cancer
    Paolo Miccoli, Mario Miccoli, Alessandro Antonelli, Michele N Minuto · 2009 · Expert Review of Anticancer Therapy
11. Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population
    Seung Woo Kim, Choon Dong Kim, Joo Ho Chung, Kee Hwan Kwon · 2014 · Clinical and Experimental Otorhinolaryngology
12. Novel RET Proto-oncogene variants identified in Turkish patients with thyroid carcinoma
    Şengül Tural, Melek Yüce, Ayfer Kamalı Polat, Esra Tekcan, Zülfinaz Betül Çelik, Ufuk Karabacak, Nurten Kara · 2020 · Gene
13. A more sensitive platform for the detection of low-abundance BRAFV600E mutations
    Weiqin Jiang, Weibin Wang, FangFang Fu, Xiaodong Teng, Haohao Wang, Haiyong Wang, Lisong Teng · 2012 · Molecular and Cellular Biochemistry
14. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
    Lizhe Ai, Yaqin Yu, Xiaoli Liu, Chong Wang, Jieping Shi, Hui Sun, Qiong Yu · 2014 · Frontiers of Medicine
15. Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility
    Catia Mio, Antonella Verrienti, Valeria Pecce, Marialuisa Sponziello, Giuseppe Damante · 2021 · Endocrine
16. Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerization
    Xingyun Su, Shitu Chen, Kuifeng He, Zhuochao Mao, Jiaying Ruan, Jie Zhou, Xiaodong Teng, Judy Jin, Thomas J. Fahey, Weibin Wang et al. · 2019 · Endocrine
17. Genetic mutations, molecular markers and future directions in research
    Patel, Kepal N. · 2013 · Oral Oncology
18. A Rare Case of Heterozygous Gain of Function Thyrotropin Receptor Mutation Associated with Development of Thyroid Follicular Carcinoma
    James Blackburn, Dinesh Giri, Barbara Ciolka, Nicole C. Gossan, Mohammad Didi, George K. Kokai, Alison J Waghorn, Matthew Jones, Senthil Senniappan · 2018 · Case Reports in Genetics
19. Diagnostic pitfalls and therapeutic outcomes of the macrofollicular variant of papillary thyroid carcinoma
    Soh‐Ching Ng, Bie‐Yu Huang, Sheng‐Fong Kuo, Chuen Hsueh, Kun‐Chun Chiang, Chih‐Hung Chen, Jen‐Der Lin · 2019 · Biomedical Journal
20. Association Analysis ofMETGene Polymorphism with Papillary Thyroid Carcinoma in a Chinese Population
    Lifeng Ning, Yaqin Yu, Xiaoli Liu, Lizhe Ai, Xin Zhang, Wen‐Wang Rao, Jieping Shi, Hui Sun, Qiong Yu · 2015 · International Journal of Endocrinology
21. Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma
    Ying Liu, Zhi Li, Xinyue Tang, Min Li, Feng Shi · 2019 · Recent Patents on Anti-Cancer Drug Discovery
22. NOS3 Gene Polymorphisms (rs2070744 and rs1799983) and Differentiated Thyroid Cancer: Investigating Associations with Clinical Outcomes
    Robert Aurelian Tiucă, Raluca-Monica Pop, Oana Mirela Tiucă, Claudia Violeta Bănescu, A. C. Carstea, Cristina Preda, Ionela Maria Pascanu · 2025 · International Journal of Molecular Sciences
23. Cellular and Molecular Pathology of Head and Neck Tumors
    Adel K. El‐Naggar · 2016 · Springer eBooks
24. Molecular Genetics of Thyroid Cancer
    Nicholas Mitsiades, James A. Fagin · 2010 · Elsevier eBooks
25. p53 antibody: is it an indicator of dedifferentiated thyroid cancer?
    Zekiye Hasbek, Bülent Turgut, Taner Erselcan · 2013 · Annals of Nuclear Medicine
26. Pathology and Classification of Thyroid Tumors
    Gretchen E. Galliano, David P. Frishberg · 2011 · Endocrine updates
27. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer
    Fang Wang, Dehui Yan, Xu Ji, Jun Han, Meijun Chen, Hong Qiao, Shaojun Zhang · 2016 · Oncotarget
28. Association of AXIN1 rs12921862 C/A and rs1805105 G/A and CTSB rs12898 G/A polymorphisms with papillary thyroid carcinoma: A case–control study
    Shaghayegh Saljooghi, Zahra Heidari, Mohsen Saravani, Mahnaz Rezaei, Saeedeh Salimi · 2022 · Journal of Clinical Laboratory Analysis
29. Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodules
    Markus Eszlinger, Holger Jaeschke, Ralf Paschke · 2007 · Current Opinion in Endocrinology Diabetes and Obesity
30. Surgical management of thyroid tumor: single institutional experience of Eastern province of Saudi Arabia
    Ali A. A. Al bshabshe · 2014 · Korean Journal of Clinical Oncology
31. Computational Analysis on the Role of GPM6A in Human Thyroid Cancer
    Zoya Khalid, Sheema Sameen, Shaukat Iqbal Malik, Sheeba Shehzad · 2012 · Journal of Data Mining in Genomics & Proteomics
32. Carcinoma papilífero da tireoide e suas variantes histológicas associados à tireoidite de Hashimoto
    Murilo Pedreira Neves, Marcos Pedro Guedes Camandaroba, Marco Antônio Cardoso de Almeida, Júlia Souto Miranda · 2009 · Jornal Brasileiro de Patologia e Medicina Laboratorial
33. Innovative In Vitro Chemo-Hormonal Drug Therapy for Refractory Thyroid Carcinomas
    Tae‐Yon Sung, Sung Ho Choi, Jung Min Lee, Jong Ju Jeong, Sang‐Wook Kang, Woong Youn Chung · 2012 · Journal of Korean Medical Science
34. MSI and LOH in the development and prognosis of follicular cell-derived thyroid tumours.
    Monika Migdalska‐Sęk, Dorota Pastuszak‐Lewandoska, Ewa Brzeziańska‐Lasota · 2012 · PubMed
35. Papillary Thyroid Carcinoma
    Vânia Nosé · 2018 · Elsevier eBooks
36. Problems in Diagnosis and Management of Follicular Neoplasm
    Won Bae Kim · 2012 · Journal of Korean Thyroid Association
37. Enlarging neck masses in the elderly – Histological and surgical considerations
    Michael O’Sullivan, K.S. McAnena, Ciara Egan, P.S. Waters, Patrick J. McCann, Michael Joseph Kerin · 2013 · International Journal of Surgery Case Reports
38. Thyroid Cancer in Children
    Daniel J. Ledbetter · 2017 · Springer eBooks
39. New techniques
    Victor Lee, Siok‐Bian Ng, Manuel Salto‐Tellez · 2010 · Elsevier eBooks
40. Clinical Response with Sunitinib Therapy in the Treatment of Anaplastic Thyroid Cancer
    Kenneth M. Wong, Theodore Scott Nowicki, Carmelo A. Puccio, Tauseef Ahmed, Raj Ranjan Tiwari, Jan Geliebter, Augustine L. Moscatello · 2012 · Journal of Cancer Therapy
41. Demystifying molecular techniques in cytopathology practice
    Fernando Carlos Schmitt, Adhemar Longatto‐Filho, Alexander Valent, Philippe R. Vielh · 2008 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
42. The Management of Thyroid Nodules and Cancer in the Molecular Era
    Ling Hui Zhou, Kepal Narendra Patel · 2015 · International Journal of Endocrine Oncology
43. RET and Thyroid Carcinomas
    Maria Domenica Castellone, Giancarlo Vecchio · 2015 · Springer eBooks
44. Nature and outcome of malignant goiter: a revisit
    Mohamed Yasser Ibrahim Daoud · 2021 · Pan African Medical Journal
45. Current trends in thyroid cancer diagnostics
    О. С. Ларін, С. М. Черенько, З. Г. Крушинська, О. В. Черненко, Oksana Sulaieva · 2017 · Clinical endocrinology and endocrine surgery
46. Correlation of the Expression of BRAF V600E Mutation With Various Phenotypic Expressions of Thyroid Neoplasms
    Volga Harikrishnan, Shantha Kumari, Subramaniam Ramkumar, Ramalingam Sankaran, Sudha Ramalingam, Thiagarajan Sairam · 2021 · Cureus
47. The Role of BRAF Mutation (V600E) in Papillary Thyroid Carcinoma (PTC)
    Azhar Azher · 2020 · Indian Journal of Forensic Medicine & Toxicology
48. Tumors of Thyroid Gland: Non-C cell Tumors
    Ashraf Ali Khan, Manju Lata Prasad · 2009 · Humana Press eBooks
49. Follicular Thyroid Cancer: Special Aspects in Children and Adolescents
    Steven Gerard Waguespack, Andrew J. Bauer · 2016 · Springer eBooks
50. Thyroid and Parathyroid Tumors
    Diana Bell, Michelle D. Williams, Adel K. El‐Naggar · 2020 · Springer eBooks
51. Thyroid Surgery: Current Trends and Recent Innovations
    Charlie T. Huins, Neil Tolley · 2010 · Springer eBooks
52. Oncogenesis and Molecular Targeted Therapy in Thyroid Cancer
    Kepal Narendra Patel, Bhuvanesh Singh · 2010
53. BRAF V600E mutation in papillary thyroid carcinoma: a potential target for therapy?
    Paula Soares, Ana Preto, Manuel A. Sobrinho-Simões · 2009 · Expert Review of Endocrinology & Metabolism
54. In Silico Mining of RAS Gene Family Expression Data in Human Thyroid Cancer
    Zoya Khalid, Sheema Sameen, Shaukat Iqbal Malik · 2011 · International Conference on Bioinformatics and Biomedical Engineering
55. Genetic susceptibility to thyroid cancer : contributions of RET polymorphisms
    Marina Santos · 2012 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
56. MSI and LOH in the development and prognosis of follicular cell-derived thyroid tumours MSI i LOH w rozwoju i prognozowaniu przebiegu nowotworów wywodzących się z komórki pęcherzykowej tarczycy
    Monika Migdalska‐Sęk, Dorota Pastuszak‐Lewandoska · 2012
57. Molecular Risk Stratification of Well-Differentiated Thyroid Cancer
    Todd P W McMullen, David C. Williams · 2015 · Head and neck cancer clinics
58. Estudo dos genes DICER1 e C8orf48 em formas familiares de bócio multinodular e cancro da tiróide
    Grau de Mestre, Doutor Valeriano Leite · 2013
59. Thyroid Cancer in Children and Adolescents
    Young Ah Lee, Andrew J. Bauer · 2019 · Springer eBooks
60. Principles of Translational Medicine and Applications to Thyroid Cancer Investigation
    Emily Gallagher, Derek LeRoith · 2011 · CRC Press eBooks
61. Rare Tumors of Childhood
    Karen H. Albritton, John M. Goldberg, Alberto S. Pappo · 2009 · Elsevier eBooks
62. 甲状腺乳頭癌におけるBRAF(VE1)蛋白発現の臨床病理学的検討
    沖野 和麿, 塩沢 英輔, 佐々木 陽介, 田澤咲子, 野呂瀬 朋子, 本間まゆみ, 淑子 矢持, 玄秀 楯, 雅文 瀧本 · 2016 · Journal of The Showa University Society
63. Molekularzytogenetische und molekulargenetische Untersuchungen an Schilddrüsentumoren
    Norbert Drieschner · 2012 · State and University Library Bremen
64. Estudo imuno-histoquímico da fosfo-histona-3 (serina-10) em neoplasias de tireóide
    Juliana Mota Pereira · 2015
65. Diagnostic Values of CD56 Marker in Differentiating Papillary Thyroid Carcinoma from Benign Follicular Lesions
    Shahram Bagheri, Sarah Nazarpour, Samin Khan Nejad · 2019 · AMBIENT SCIENCE
66. Head and Neck
    Michelle D. Williams, Adel K. El‐Naggar · 2009 · Elsevier eBooks
67. Papillary Thyroid Carcinoma, Classic Variant
    Vânia Nosé · 2018 · Elsevier eBooks
68. Innovative therapy for refractory thyroid carcinomas
    성태연 · 2012
69. Head and Neck
    Michelle D. Williams, Adel K. El‐Naggar · 2021 · Elsevier eBooks
70. Hürthle Cell Carcinoma
    Inga‐Lena Nilsson · 2021 · Springer eBooks
71. Thyroid
    Giorgio Gherardi · 2009 · Springer eBooks
72. Current World Literature
    2007 · Current Opinion in Endocrinology Diabetes and Obesity
73. The epidemiology and aetiology of a rising incidence of papillary thyroid carcinoma in Tasmania
    John R. Burgess · 2007 · Figshare
74. Nature and outcome of malignant goiter: a single institutional experience from the eastern province of Saudi Arabia
    Mohamed Yasser Ibrahim Daoud, Ossama Mohammed Zakaria, Abdul Mohsen Al Suwaigh · 2020
75. Papillary Thyroid Carcinoma, Classic Variant
    2018 · Elsevier eBooks
76. Thyroid Cancer in Children and Adolescents
    Andrew J. Bauer · 2019 · Elsevier eBooks
77. Data from A Comprehensive Meta-analysis of Case–Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma
    Gisella Figlioli, Rossella Elisei, Cristina Romei, Ombretta Melaiu, Monica Cipollini, Franco Bambi, Bowang Chen, Aleksandra Köhler, Alfonso Cristaudo, Kari Hemminki et al. · 2023
78. An affordable immunohistochemical approach to estimate the prevalence of BRAF V600E mutation in papillary thyroid cancer patients of King Chulalongkorn Memorial Hospital, Thailand.
    Sonam Choden, Somboon Keelawat · 2019
79. Genome-wide association and expression analyses of programmed cell death associated genes provide novel insight into therapeutic target in differentiated thyroid cancer
    Qinnan Zhang, Nan An, Xueqing Li, Panpan Zhang, Qian Yang, Fanfan Pan, Kai Wang, Bingbing Zha · 2024 · Research Square
80. Genome-wide association and expression analyses of programmed cell death provide novel insights into therapeutic targets in differentiated thyroid cancer
    Qinnan Zhang, Nan An, Xueqing Li, Panpan Zhang, Kai Wang, Bingbing Zha · 2024 · Research Square
81. Development of NMR methodology for the analysis and simplification of complex mixtures
    Jima N. Chandran · 2013
82. FOXE1, IMP-3, and TERT expressions in papillary thyroid carcinomas
    Nurtaç Asa Sarıkaş, Nuray Can, Necdet Süt, Yavuz Atakan Sezer, Buket Yılmaz Bülbül, Ebru Tastekin, Ufuk Usta, Fulya Öz Puyan, T. Deniz Yalta, Funda Üstün · 2026 · Indian Journal of Pathology and Microbiology